| Literature DB >> 15920011 |
Christine Chauveau1, Séverine Rémy, Pierre Joseph Royer, Marcelo Hill, Séverine Tanguy-Royer, François-Xavier Hubert, Laurent Tesson, Régis Brion, Gaëlle Beriou, Marc Gregoire, Régis Josien, Maria Cristina Cuturi, Ignacio Anegon.
Abstract
Heme oxygenase-1 (HO-1) is an intracellular enzyme that degrades heme and inhibits immune responses and inflammation in vivo. In most cell types, HO-1 is inducible by inflammatory stimuli and oxidative stress. Here we demonstrate that human monocyte-derived immature dendritic cells (iDCs) and several but not all freshly isolated rat splenic DC subsets and rat bone marrow-derived iDCs, spontaneously express HO-1. HO-1 expression drastically decreases during human and rat DC maturation induced in vitro. In human tissues, iDCs also express HO-1, whereas mature DCs do not. Induction of HO-1 expression with cobalt protoporphyrin (CoPP) in human and rat DCs inhibits lipopolysaccharide (LPS)-induced phenotypic maturation and secretion of proinflammatory cytokines, resulting in the inhibition of alloreactive T-cell proliferation. CoPP-treated DCs, however, retain the ability to produce the anti-inflammatory cytokine interleukin 10 (IL-10). Reactive oxygen species induced by LPS in DCs were inhibited by induction of HO-1. In conclusion, we identify, for the first time, the capacity of HO-1 to block maturation of DCs and to inhibit proinflammatory and allogeneic immune responses while preserving IL-10 production. This novel immune function for HO-1 may be of interest for the inhibition of immune responses in autoimmune diseases, transplantation, and other conditions involving activation of the immune system.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15920011 DOI: 10.1182/blood-2005-02-0494
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113